Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorComerford, I.-
dc.contributor.authorNibbs, R.-
dc.contributor.authorLitchfield, W.-
dc.contributor.authorBunting, M.-
dc.contributor.authorHarata-Lee, Y.-
dc.contributor.authorHaylock-Jacobs, S.-
dc.contributor.authorForrow, S.-
dc.contributor.authorKorner, H.-
dc.contributor.authorMcColl, S.-
dc.identifier.citationBlood, 2010; 116(20):4130-4140-
dc.description.abstractOur previous in vitro studies led to proposals that the atypical chemokine receptor CCX-CKR is a scavenger of CCR7 ligand homeostatic chemokines. In the present study, we generated CCX-CKR(-/-) mice and confirm this scavenger function in vivo. Compared with wild-type mice, CCX-CKR(-/-) have a 5-fold increase in the level of CCL21 protein in blood, and 2- to 3-fold increases in CCL19 and CCL21 in peripheral lymph nodes. The effect of these protein increases on immunity was investigated after immunization with MOG(35-55) peptide emulsified in complete Freund adjuvant (CFA). The subsequent characteristic paralysis develops with enhanced kinetics and severity in CCX-CKR(-/-) versus wild-type mice. Despite this effect, antigen-specific immune responses in the draining lymph nodes are diminished in CCX-CKR(-/-) mice. Instead, the earlier onset of disease is associated with enhanced T-cell priming in the CCX-CKR(-/-) spleen and a skewing of CD4(+) T-cell responses toward Th17 rather than Th1. This observation correlates with increased expression of IL-23 in the CCX-CKR(-/-) spleen and increased CCL21 levels in the central nervous system postimmunization. The early onset of disease in CCX-CKR(-/-) mice is reversed by systemic administration of neutralizing anti-CCL21 antibodies. Thus, by regulating homeostatic chemokine bioavailability, CCX-CKR influences the localization, kinetics, and nature of adaptive immune responses in vivo.-
dc.description.statementofresponsibilityIain Comerford, Robert J. B. Nibbs, Wendel Litchfield, Mark Bunting, Yuka Harata-Lee, Sarah Haylock-Jacobs, Steve Forrow, Heinrich Korner and Shaun R. McColl-
dc.publisherAmer Soc Hematology-
dc.rightsCopyright 2010 by The American Society of Hematology; all rights reserved.-
dc.subjectCentral Nervous System-
dc.subjectLymph Nodes-
dc.subjectTh1 Cells-
dc.subjectMice, Inbred C57BL-
dc.subjectEncephalomyelitis, Autoimmune, Experimental-
dc.subjectReceptors, Chemokine-
dc.subjectNeutralization Tests-
dc.subjectOrgan Specificity-
dc.subjectChemokine CCL19-
dc.subjectChemokine CCL21-
dc.subjectTh17 Cells-
dc.titleThe atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses-
dc.typeJournal article-
dc.identifier.orcidBunting, M. [0000-0002-7575-4910]-
dc.identifier.orcidMcColl, S. [0000-0003-0949-4660]-
Appears in Collections:Aurora harvest 5
IPAS publications
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.